IGF‐I is important for regulating and maintaining the invasive and metastatic properties of the malignant phenotype [71], whereas TGF‐β exhibits both tumor‐suppressive and tumor‐promotive properties [72] and is a key regulator of the epithelial–mesenchymal transition (EMT). The gene discussed is IGF1; the disease is neoplasm.